Table 7.

Clinical consequences and medicines of reported medication errors

Country	Type of error	Medicines	Clinical consequences	Reference
Israel	Prescribing	Anti-infectives, TPN, cytotoxics	Errors divided into potentially serious, clinically significant and clinically non-significant. MEs most frequent in haemato-oncology and these were the errors that were of greatest clinical significance	[14]
Saudi Arabia	Prescribing	Not stated	Examples of potentially serious errors were given including tenfold errors of amphotericin and captopril	[26]
Israel	Prescribing	Cardiovascular drugs	14 MEs (8 %) were clinically significant. There were also 3 (2 %) severe MEs	[30]
Saudi Arabia	Prescribing	IV fluids, antibiotics, bronchodilators, opioid analgesics, cardiovascular drugs, sedatives	Majority of MEs were potentially harmful (1051, 79 %)	[21]
Saudi Arabia	Prescribing	Antibiotics, cardiovascular drugs	MEs were a contributory factor to 26 deaths	[31]
Iran	Administration	Antibiotics, antacids, corticosteroids	No clinically significant errors detected	[38]